News
The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...
Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection ...
The risk of dying from the most common form of primary liver cancer is approximately 30% higher for patients with low ...
Berlin: Bayer has announced the initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational ...
Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...
Alexis McCarthy, a freshman at South Glens Falls High, is recovering from a successful surgery to remove a rare childhood ...
By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...
Each year, some 500-550 people in Sweden are diagnosed with what is known as hepatocellular carcinoma, or HCC for short, which is the most common form of primary liver cancer, in other words ...
5d
News-Medical.Net on MSNSemaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial showsA phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
TWO toilet related symptoms could be the first signs of a hard-to-spot cancer that’s on the rise in the UK. Bile duct cancer ...
Each year, some 500–550 people in Sweden are diagnosed with what is known as hepatocellular carcinoma, or HCC for short, which is the most common form of primary liver cancer, in other words ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results